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Abstract
Background
Chronic kidney disease (CKD) is a growing contributor to the global burden of noncommu-
nicable diseases. Early diagnosis and treatment can reduce the severity of kidney damage
and the need for dialysis or transplantation. It is not known whether mild-to-moderate renal
pelvis dilatation (RPD) identified at 18–20 weeks gestation is an early indicator of renal
pathology. The aim of this follow-up to the Welsh Study of Mothers and Babies was to
assess the risk of hospital admission in children with mild-to-moderate antenatal RPD com-
pared with children without this finding. We also examined how the natural history of the
RPD (whether the dilatation persists in later pregnancy or postpartum) or its characteristics
(unilateral versus bilateral) changed the risk of hospital admission.
Methods/Findings
This population-based cohort study included singleton babies born in Wales between Janu-
ary 1, 2009, and December 31, 2011 (n = 22,045). We linked ultrasound scan data to rou-
tinely available data on hospital admissions from the Patient Episode Database for Wales
(PEDW). The outcome was a hospital admission for urinary tract causes (defined by an
expert study steering group) in the first three years of life. We used Cox regression to model
time to first hospital admission, according to whether there was evidence of RPD at the fetal
anomaly scan (FAS) and/or evidence of dilatation in later investigations, adjusting for other
predictors of admission. We used multiple imputation with chained equations to impute val-
ues for missing data. We included 21,239 children in the analysis. The risk of at least one
hospital admission was seven times greater in those with RPD (n = 138) compared with
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those without (n = 21,101, conditional hazard ratio [cHR] 7.23, 95% confidence interval [CI]
4.31–12.15, p < 0.001). The risk of hospital admission was higher in children with RPD at
the FAS and later dilatation (cHR 25.13, 95% CI 13.26–47.64, p < 0.001) and in children
without RPD at the FAS who had later dilatation (cHR 62.06, 95% CI 41.10–93.71, p <
0.001) than in children without RPD (n = 21,057). Among children with RPD at the FAS but
no dilatation in later pregnancy or postpartum, we did not find an association with hospital
admissions (cHR 2.16, 95% CI 0.69–6.75, p = 0.185), except when the initial dilatation was
bilateral (cHR 4.77, 95% CI 1.17–19.47, p = 0.029). Limitations of the study include small
numbers in subgroups (meaning that these results should be interpreted with caution), that
less severe outcomes (such as urinary tract infections [UTIs] managed in the community or
in outpatients) could not be included in our analysis, and that obtaining records of radiologi-
cal investigations later in pregnancy and postpartum was challenging. Our conclusions were
consistent after conducting sensitivity analyses to account for some of these limitations.
Conclusions
In this large population-based study, children with RPD at the FAS had higher rates of hospi-
tal admissions when there was persistent dilatation in later pregnancy or postpartum. Our
results can be used to improve counselling of parents and develop care pathways for antena-
tal screening programmes, including protocols for reporting and further investigation of RPD.
Author summary
Why was this study done?
• Pregnant women usually have an ultrasound scan when they are about 20 weeks preg-
nant. The purpose of this anomaly scan is to look for structural abnormalities, such as
abnormal growth or development of organs.
• It is not known if some of the findings at this scan are indicators of health problems.
• For example, fluid-filled areas in the baby’s kidneys (called ‘renal pelvis dilatation’) are
sometimes seen, but it is not known whether these are associated with adverse outcomes
in childhood.
What did the researchers do and find?
• In this study, children with renal pelvis dilatation, and a group of children who did not
have this finding, were followed until they were three years old.
• Babies who had this dilatation were more likely to be admitted to hospital with problems
in the kidneys and urinary tract than children without dilatation, especially if the finding
was still present later in pregnancy or after the birth (HR 25.13, 95% CI 13.26–47.64, p
< 0.001). In children with dilatation at the anomaly scan, but no dilatation in later preg-
nancy or postpartum, we did not find an association with hospital admissions (HR 2.16,
95% CI 0.69–6.75, p = 0.185), except when the initial dilatation was in both kidneys (HR
4.77, 95% CI 1.17–19.47, p = 0.029).
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PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002859 July 30, 2019 2 / 17
ensure proper and appropriate use of SAIL data.
When access has been granted, it is gained
through a privacy-protecting safe haven and
remote access system referred to as the SAIL
Gateway. Relevant information to allow acquisition
of a replicable data set is available in the paper and
its Supporting Information files, or can be
requested from the authors. Please contact
SAILDatabank@swansea.ac.uk for more detail on
data access requests.
Funding: The Welsh Study of Mothers and Babies
was funded by a grant to SP (principal investigator)
from the Welsh Assembly Government and MRC
Health Research Partnership scheme (reference
number RFSH07340). This follow-up study was
funded by a grant to SP (principal investigator) by
the National Institute for Social Care and Health
Research (reference number RFPPB-2012-1046).
The funders had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Abbreviations: ALF, anonymised linking field; AP,
anterior-posterior; CAKUT, congenital anomalies of
the kidney and urinary tract; CARIS, Congenital
Anomaly Register for Wales; cHR, conditional
hazard ratio; CI, confidence interval; CKD, chronic
kidney disease; FAS, fetal anomaly scan; HR,
hazard ratio; ICD-10, International Statistical
Classification of Diseases and Related Health
Problems, 10th Revision; IQR, interquartile range;
NHS, National Health Service; OPCS, Operating
Procedure Codes; PEDW, Patient Episode
Database for Wales; QA, quality assurance;
RadIS2, Radiology Information Service 2; RPD,
renal pelvis dilatation; SAIL, Secure Anonymised
Information Linkage; UTI, urinary tract infection.
What do these findings mean?
• These results can be used to improve counselling of parents and to develop care path-
ways for antenatal screening programmes, including protocols for reporting and further
investigation of renal pelvis dilatation.
Introduction
Chronic kidney disease (CKD) is a growing contributor to the global burden of noncommu-
nicable diseases [1,2]. Although relatively rare in children [1], management of CKD in paediat-
ric patients is complex and costly [1,2], and the condition has a profound impact on children
and their families [3]. Approximately half of all cases of CKD in children in high income coun-
tries are due to congenital anomalies of the kidney and urinary tract (CAKUT) [4,5]. Early
diagnosis and treatment can reduce the severity of kidney damage and the need for dialysis or
transplantation [6,7].
Routine investigations during pregnancy are an opportunity to screen for CAKUT. In the
United Kingdom, all women are offered an ultrasound scan at 18 to 20 weeks gestation to
detect major anomalies in the fetus. The National Health Service (NHS)’s Fetal Anomaly
Screening Programme specifies that 11 structural abnormalities are detectable at this scan,
including one CAKUT (bilateral renal agenesis) [8], but other abnormalities of the kidney
and urinary tract can also be identified [4,7]. One such finding is dilatation of the fetal renal
pelvis (the collecting system where urine flows from the kidney into the ureter), detected by
measuring the anterior-posterior (AP) diameter of the renal pelvis. This is also known as
hydronephrosis, pelvicalyceal dilatation, pelviectasis, or pyelectasis [9]. Current UK guid-
ance recommends that this finding should be reported and assessed further [8,10]. However,
different classification systems exist, which use different criteria and nomenclature to distin-
guish between potential pathological dilatation and transient changes that are of limited
clinical significance [6,11,12], leading to inconsistent management and parental anxiety
[13,14].
Measurement thresholds based on ‘best available evidence. . .[of] prognostic information’
have been proposed [6], with AP dilatation in the second trimester of 4- to<7-mm classified
as mild, 7- to�10-mm as moderate, and >10-mm as severe. Third trimester AP thresholds of
7- to<9-mm are classified as mild, 9- to�15-mm as moderate, and>15-mm as severe. Severe
dilatation is reported to be associated with postnatal pathology in almost 90% of cases [15].
However, previous studies examining the sequelae of mild or moderate antenatal dilatation
have found conflicting results, have several methodological limitations, and have been assessed
to be of low or moderate quality [15–21]. These have not therefore led to the development of
consistent care pathways [12,22,23].
The Welsh Study of Mothers and Babies is a prospective, population-based cohort that was
established to examine childhood morbidity associated with ultrasound findings of unknown
significance detected at the fetal anomaly scan (FAS). We analysed data from this cohort with
the aim of assessing the risk of hospital admission in the first three years of life associated with
mild-to-moderate antenatal renal pelvis dilatation (RPD). We also examined how the natural
history of the RPD (whether the dilatation persists in later pregnancy or postpartum) or its
characteristics (unilateral versus bilateral) changed the risk of hospital admission.
Antenatal renal pelvis dilatation and hospital admissions in childhood
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Methods
The Welsh Study of Mothers and Babies recruited a cohort of pregnant women receiving ante-
natal care in Wales between 2008 and 2011, to estimate the prevalence of seven nonstructural
findings at the FAS and examine their association with pregnancy outcomes and longer-term
health outcomes [24]. Ethical approval for the original study was given by the Multicentre
Research Ethics Committee for Wales (reference 08/MRE09/17) on April 16, 2008.
Study population
All pregnant women who had a second trimester FAS in six of seven Welsh Health Boards
between July 2008 and March 2011 were eligible for inclusion. At recruitment, women were
asked to give written consent that the data from their ultrasound scan could be linked with
routinely collected data on their child.
Inclusion and exclusion criteria
The population for this analysis was singleton children who were live-born between January 1,
2009, and December 31, 2011, to mothers in Wales who consented to take part in the study
and for whom validated FAS data were available (Fig 1). Pregnancies with an unknown out-
come (for example, because the birth happened outside of Wales) were excluded. Children
whose information could not be assigned an anonymised linking field (ALF; for example,
because they did not receive their healthcare in Wales or did not have a valid NHS number or
other identification variables) were also excluded, as linkage with the healthcare datasets was
not possible. Children were followed from birth until the occurrence of death, migration out
of Wales, 3rd birthday, or December 31, 2014 (end of follow-up). Person-time was censored in
cases of death and migration.
Definition of exposure
RPD was defined as fluid-filled dilatation of the renal pelvis measured on the axial section,
with an AP diameter of 5.0 to 9.9 mm (with the callipers to be placed on the inner AP margins
of the renal pelvic wall) at the FAS [25]. An additional reporting screen was added to the infor-
mation system for radiological data storage and reporting in Wales (Radiology Information
Service 2 [RadIS2]) to capture the scan data. Data were also collected on whether the dilatation
was unilateral or bilateral. An expert quality assurance (QA) panel reviewed FAS images to
confirm the presence of dilatation in accordance with the study definition; the number of
cases of RPD reduced from 221 to 144 after this process (for detail, see [26]).
We also sought to obtain information from radiological investigations conducted later in
pregnancy from RadIS2 and the Congenital Anomaly Register for Wales (CARIS). Data on the
presence of dilatation identified later in pregnancy and/or up to 12 months postpartum, plus
any measurements recorded, were extracted from radiological reports. In accordance with
international guidance [6,12], measurements of 7.1 mm or greater later in pregnancy or post-
partum were considered evidence of later dilatation. The exposure groups in the analysis were
then stratified into (i) no RPD at FAS or later, (ii) no RPD at FAS but RPD present later, (iii)
RPD at FAS but not later, and (iv) RPD at FAS and later (Fig 2).
Definition of outcomes
The outcome was a hospital admission for urinary tract causes in the first three years of life.
An admission was defined as a continuous stay using a hospital bed provided by the NHS in
Wales under one or more consultants, and included transfers between hospitals. A list of codes
Antenatal renal pelvis dilatation and hospital admissions in childhood
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for possible causes of admissions in children for which RPD could be considered a possible
precursor (including renal and lower urinary tract problems) was agreed by the study steering
Fig 1. Cohort flow diagram. ALF, anonymised linking field; QA, quality assurance; RPD, renal pelvis dilatation.
https://doi.org/10.1371/journal.pmed.1002859.g001
Antenatal renal pelvis dilatation and hospital admissions in childhood
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group, which included a consultant paediatric nephrologist, consultant radiologists, and an
academic general practitioner (see S1 Table). The list was based on the International Statistical
Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) [27] and the
procedure code list used in the NHS (Operating Procedure Codes Classification of Interven-
tions and Procedures version 4 or OPCS-4) [28]. Hospital admissions with any of these codes
in any coding position were identified from the Patient Episode Database for Wales (PEDW).
Admissions as a day case for postnatal investigations alone are not a part of this dataset, and
these admissions would not therefore have been included.
Data linkage
Data from the Welsh Study of Mothers and Babies were exported to the Secure Anonymised
Information Linkage (SAIL) Databank [29] to enable the radiological data to be linked with
data on hospital admissions (from PEDW), congenital anomalies (from CARIS), deaths (from
the Office for National Statistics Annual District Death Extract), and migration (from the
Welsh Demographic Service data). For each of these datasets, individuals were assigned a
unique identifier (the ALF) provided by the NHS Wales Informatics Service. The linkage sys-
tem uses a combination of deterministic (based on NHS numbers) and probabilistic record
linkage (based on first name, surname, date of birth, gender, and phonex and soundex versions
of names); this linkage is more than 99.85% accurate [30]. Second-stage encryption is used by
the data bank before storing data, and third-stage encryption is used to create project-specific
Fig 2. Definition of exposure groups for the analysis, and characteristics of hospital admissions. IQR, interquartile range; RPD, renal pelvis dilatation; UTI, urinary
tract infection.
https://doi.org/10.1371/journal.pmed.1002859.g002
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linked datasets. Approval from the Information Governance Review Panel of the SAIL Data-
bank was obtained for the analysis.
Sample size
Preliminary analyses of PEDW data showed that 2 per 100 children were admitted to hospital
with a urinary tract cause before the age of five years. We therefore estimated that we would
need approximately 21,000 children without RPD and 140 children with RPD to detect, at a
5% type 1 error rate, a 3-fold increase in urinary tract hospital admissions with RPD with 80%
power. There were enough children in our cohort for this analysis.
Statistical methods
The statistical analysis was planned by the investigators of the study, in collaboration with the
study steering group, in advance of the conduct of the analysis (for detail, see [24] and the pro-
tocol for this analysis, S1 Renal Study Protocol). This included the specification of the ICD-10
codes to be included in the definition of the outcome. An initial analysis of the association
between RPD and hospitalisations was presented to the study steering group in 2016, and they
recommended that the additional radiological data (from later pregnancy and postpartum)
were sought and added to the analyses. We used Cox regression to model time to the first uri-
nary tract hospital admission to three years of age. Our primary outcome was time to first hos-
pital admission because most children with an admission were only admitted once (81.3%).
We estimated hazard ratios (HRs) with 95% confidence intervals (CIs) to examine the risk of
hospital admissions associated with the presence of RPD at the FAS, and then according to
whether the child had RPD and/or later dilatation. The proportional hazards assumption was
assessed graphically using log-minus-log plots and was tested based on the Schoenfeld residu-
als. We originally planned to include follow-up time until the child’s fifth birthday, but there
was evidence that the proportional hazards assumption was violated in this analysis because all
of the admissions in the RPD group occurred before the age of three years, whereas children
without RPD continued to be admitted for the first time after three years of age. Based on this
and on peer review comments, we chose a cutoff of three years of age for the follow-up period
(instead of the preplanned five years), and formal testing confirmed there was no strong evi-
dence that the proportional hazards assumption was violated in these models (for example,
p = 0.11 for the binary RPD variable). Conclusions from models including five years of follow-
up were similar to the models including three years of follow-up.
We examined associations in unadjusted models and conditional on other predictors of
hospital admissions (sex, maternal age in three categories [<25, 25–34, 35+ years], deprivation
quintile based on the UK Townsend Deprivation Score [31], and prematurity). We repeated
the analyses to estimate HRs stratified according to whether the RPD was unilateral or bilat-
eral. We also conducted sensitivity analyses: (i) adding information on dilatation identified
during hospital admissions into the definition of exposure subgroups (that is, also using codes
Q62.0, N13.0, N13.1, N13.2, or N13.3 in any position for a PEDW admission as evidence of
later dilatation) and (ii) using an Anderson-Gill model to account for multiple urinary tract
admissions during the follow-up period.
Data from radiological investigations to assess for dilatation later in pregnancy or postpar-
tum were missing for 50 of the 138 children with RPD. There was also a low percentage of chil-
dren with missing data on covariates (0.7% for Townsend score, 0.3% for prematurity).
Multiple imputation with chained equations [32] was used to impute values for the missing
data (10 imputations) under the missing at random assumption. The imputation model
included all covariates, the outcome variable (urinary tract admissions), and the cumulative
Antenatal renal pelvis dilatation and hospital admissions in childhood
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002859 July 30, 2019 7 / 17
baseline hazard [33]. Conclusions from a complete case analysis and from the multiple imputa-
tion were similar. In response to peer-review comments, we present the results from the multi-
ply imputed datasets.
All analyses were conducted within the SAIL Gateway using Stata version 15.1.
The study is reported as per the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) guideline (see S1 STROBE Checklist).
Results
Anomaly scan data were available for 22,045 children (Fig 1). The characteristics and preg-
nancy outcomes of their mothers were comparable to the general population of pregnant
women in Wales [26]. Thirty-two pregnancies were excluded, as their scan images were not
available for QA for RPD. There were 81 stillbirths, 50 spontaneous or induced abortions, 607
pregnancies with no outcome data, and 25 babies who could not be assigned an anonymised
linkage field identifier, leaving 21,250 children available for analysis after data linkage. Eleven
children had dilatation of the renal pelvis measuring 10.0 mm or greater at the FAS. All of
these had evidence of a urinary tract hospital admission or significant renal pathology in inves-
tigations after birth and were excluded from all further analyses. This analysis is therefore
based on 21,239 children (96.3% of those with scan data) who contributed 61,984 child-years
of follow-up.
A total of 138 children (0.7%) had confirmed RPD at the FAS (Table 1). RPD was more
prevalent in male than female children (0.9% compared with 0.4%) and in children of younger
mothers (0.9% when maternal age was<25), but there was no association with area-level social
deprivation, prematurity, or low birth weight. Overall, 1.8% of the children had at least one
admission for a urinary tract problem during follow-up (Table 2). Girls were more likely than
boys to have at least one admission, as were children of younger mothers and premature
children.
Of the 21,101 children with no RPD at the FAS, 20,534 (97.3%) had no further investiga-
tions and 567 (2.7%) did (see Fig 2). Most of the 567 had no evidence of RPD at the later inves-
tigations (n = 523, 92.2%). In the group with no RPD at the FAS and no evidence of later
dilatation or later investigations (n = 21,057), there were 333 children with at least one urinary
tract hospital admission (1.6%). Most of these had only one admission (86.8%). The median
age at first admission was 6 months (interquartile range [IQR] 2–14), and the commonest
code linked to the first and all admissions was urinary tract infection (UTI; ICD-10 codes
N39.0, N39.1, or P39.3).
A total of 26 of the 44 children (59.1%) with no RPD at the FAS but evidence of dilatation
at later investigations had at least one urinary tract hospital admission, and most had more
than one admission. The median age at first admission was three months (IQR 1–6), and the
commonest code linked to the first and all admissions was hydronephrosis (ICD-10 code
Q62.0).
Of the 138 children with RPD at the FAS, 88 (63.8%) had further investigations. A total of
59 of the 88 had no evidence of dilatation at the later investigations, and there were fewer than
five hospital admissions in this group. No further investigations were found for 50 of the 138,
and there were also fewer than five hospital admissions in this group. As described above, mul-
tiple imputation was used to account for the missing data on later dilatation in these children.
A total of 29 children with RPD at the FAS had evidence of later dilatation; 11 of these
(37.9%) had at least one hospital admission for a urinary tract cause, and most had more than
one admission. The median age at first admission was two months (IQR 0–15), and the com-
monest code linked to the first and all admissions was hydronephrosis (ICD-10 code Q62.0).
Antenatal renal pelvis dilatation and hospital admissions in childhood
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Further details on the characteristics of first and all admissions for all groups are summarised
in the supporting information (S2 Table and S3 Table).
The risk of at least one hospital admission was seven times greater in those with RPD (n =
21,101) compared with those without (n = 138, conditional HR [cHR] 7.23, 95% CI 4.31–12.15,
p< 0.001, Table 3). Table 3 also shows the hazard ratios when the data were further stratified
according to whether there was evidence of dilatation in later radiological investigations. Com-
pared to those with no RPD and no later dilatation, the risk of urinary tract hospital admissions
was higher in children with no RPD but dilatation detected later (cHR 62.06, 95% CI 41.10–
93.71, p< 0.001). It was also higher in children with RPD and later dilatation (cHR 25.13, 95%
CI 13.26–47.64, p< 0.001), but not in children with RPD and no later dilatation (cHR 2.16,
95% CI 0.69–6.75, p = 0.185). We also did not detect a difference at the 5% level in hospital
admission rates between children with unilateral and bilateral RPD (Table 4). However, com-
pared with children with no RPD and no later dilatation, there was evidence that children with
bilateral RPD but no evidence of later dilatation had a higher risk of hospital admission than
children with no RPD and no later dilatation (cHR 4.77, 95% CI 1.17–19.47, p = 0.029).
The results of sensitivity analyses are presented in the supporting information (S4 Table
and S5 Table). When evidence of dilatation in the hospital admission records was included in
Table 1. Characteristics of the cohort, by RPD status at anomaly scan.
Characteristics RPD at anomaly scan
No Yes
N = 21,101 (99.3%) N = 138 (0.7%)
Number (%) Number (%)
Sex
Male 10,804 (99.1) 95 (0.9)
Female 10,297 (99.6) 43 (0.4)
Maternal age
<25 6,158 (99.1) 53 (0.9)
25–34 11,694 (99.5) 62 (0.5)
35+ 3,249 (99.3) 23 (0.7)
Townsend score�
1 3,529 (99.4) 20 (0.6)
2 3,334 (99.4) 20 (0.6)
3 4,087 (99.4) 25 (0.6)
4 4,779 (99.4) 30 (0.6)
5 5,218 (99.2) 43 (0.8)
Premature��
No 19,921 (99.3) 131 (0.7)
Yes 1,125 (99.4) 7 (0.6)
Birth weight†
�2,500 g 19,882 (99.3) 131 (0.7)
< 2,500 1,090 (99.4) 7 (0.6)
�Townsend deprivation score: 1 = least deprived, 5 = most deprived; missing data for 154 (0.7%).
��Prematurity: premature = <37 weeks gestation; missing data for 55 (0.3%).
†Missing data for 129 (0.6%); all later analyses include prematurity but not birth weight, as these two variables are
highly correlated; prematurity has fewer missing values, and the effect of the two variables in the multivariate models
was similar.
Abbreviation: RPD, renal pelvis dilatation.
https://doi.org/10.1371/journal.pmed.1002859.t001
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the definition of the exposure subgroups, the HRs for children with evidence of later dilatation
moved further away from one, whilst the estimate for children with RPD but no later dilatation
moved closer to one. Accounting for multiple admissions increased the HRs for children with
Table 2. Characteristics of the children according to whether they had at least one urinary tract admission during follow-up.
Characteristics Children with at least one urinary tract admission Predictors of urinary tract admission?
No Yes Multivariable HR p-value
N = 20,865 (98.2%) N = 374 (1.8%)
Number (%) Number (%) (95% CI)†
Sex
Male 10,737 (98.5) 162 (1.5) 1.00
Female 10,128 (97.9) 212 (2.1) 1.39 (1.14–1.71) 0.001
Maternal age
<25 6,077 (97.8) 134 (2.2) 1.39 (1.00–1.94) 0.053
25–34 11,565 (98.4) 191 (1.6) 1.00 -
35+ 3,223 (98.5) 49 (1.5) 1.07 (0.78–1.47) 0.665
Townsend score�
1 3,493 (98.4) 56 (1.6) 1.00 -
2 3,305 (98.5) 49 (1.5) 0.91 (0.62–1.34) 0.633
3 4,031 (98.0) 81 (2.0) 1.19 (0.85–1.68) 0.312
4 4,726 (98.3) 83 (1.7) 1.00 (0.71–1.46) 0.996
5 5,158 (98.0) 103 (2.0) 1.12 (0.80–1.56) 0.513
Premature��
No 19,721 (98.3) 331 (1.7) 1.00 -
Yes 1,091 (96.4) 41 (3.6) 2.29 (1.65–3.16) <0.001
�Townsend deprivation score: 1 = least deprived, 5 = most deprived; missing data for 154 (0.7%).
��Prematurity: premature = <37 weeks gestation; missing data for 55 (0.3%).
†Multivariable models include all variables in the table; missing values for Townsend score and prematurity imputed using multiple imputation.
Abbreviations: CI, confidence interval; HR, hazard ratio.
https://doi.org/10.1371/journal.pmed.1002859.t002
Table 3. HRs for time to first urinary tract hospital admission by RPD status at anomaly scan.
Time to first urinary tract hospital admission by RPD status (n = 21,239)
Univariate HR (95% CI) p-value Multivariable HR (95% CI)‡ p-value
According to the presence of RPD at the anomaly scan
No RPD at anomaly scan 1.00 - 1.00 -
RPD at anomaly scan 6.91 (4.12–11.58) <0.001 7.23 (4.31–12.15) <0.001
According to the presence of RPD at the anomaly scan and whether there is evidence of dilatation† at later investigations
No RPD and no evidence of dilatation after the anomaly scan 1.00 - 1.00 -
No RPD and evidence of dilatation after the anomaly scan 61.99 (41.54–92.49) <0.001 62.06 (41.10–93.71) <0.001
RPD and no evidence of dilatation after the anomaly scan 2.04 (0.65–6.36) 0.219 2.16 (0.69–6.75) 0.185
RPD and evidence of dilatation after the anomaly scan 23.95 (12.70–45.15) <0.001 25.13 (13.26–47.64) <0.001
†Dilatation = evidence of dilatation of�7.1 mm later in pregnancy and/or evidence of dilatation of �7.1 mm postpartum.
‡Multivariable model also includes child sex, maternal age, Townsend score, gestational age at birth (multivariable model a better fit, likelihood ratio test p< 0.0001 in
both cases).
Abbreviations: CI, confidence interval; HR, hazard ratio; RPD, renal pelvis dilatation.
https://doi.org/10.1371/journal.pmed.1002859.t003
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evidence of later dilatation, as these children were more likely to have multiple admissions, but
did not change the conclusion for children with RPD but no later dilatation.
Discussion
In this study, mild-to-moderate RPD was identified in 7.6 per 1,000 singleton pregnancies at
the fetal anomaly ultrasound scan. In most children, this dilatation did not persist, and hospital
admission rates for urinary tract problems in those children were similar to those in children
with no RPD and no later dilatation. Persistent dilatation in later pregnancy and/or postpar-
tum was rare, but children with this finding had a higher risk of hospital admission for a uri-
nary tract cause before the age of three years. Children whose dilatation was identified later in
pregnancy or postpartum had the highest risk of hospital admission.
Strengths
This was a large population-based study in a cohort that was representative of all pregnant
women in Wales. The stringent QA process was a strength of the study, with scan images
reviewed by an expert panel to confirm that all cases of RPD conformed to the study definition.
Linkage to routinely collected healthcare records was possible for 97% of women and children,
ensuring that few were lost to follow-up. Unlike previous studies, we could compare outcomes
in children with and without RPD. We used hospital admissions for urinary tract causes
(including operations but not investigations) as a proxy for significant morbidity.
Limitations
The prevalence of RPD in this study was similar to estimates in previous studies. However, the
absolute number of cases was small (n = 138), and these numbers reduced further when the
data were stratified by the presence or absence of later dilatation. The estimates from the study
must therefore be interpreted with caution. Although the small numbers mean that the CIs
around the point estimates are wide, the effect sizes for the associations examined are large,
suggesting that the sample size for examining these associations is adequate.
Table 4. HRs for time to first urinary tract hospital admission with unilateral or bilateral RPD.
Time to first urinary tract hospital admission by RPD status (n = 21,239)
Univariate HR (95% CI) p-value Multivariable HR (95% CI)‡ p-value
According to the presence of RPD at the anomaly scan
No RPD at anomaly scan 1.00 - 1.00 -
Unilateral RPD at anomaly scan 5.42 (2.69–10.92) <0.001 5.54 (2.75–11.18) <0.001
Bilateral RPD at anomaly scan 10.06 (4.76–21.25) <0.001 11.17 (5.26–23.72) < 0.001
According to the presence of RPD at the anomaly scan and whether there is evidence of dilatation† at later investigations
No RPD and no evidence of dilatation after the anomaly scan 1.00 - 1.00 -
No RPD and evidence of dilatation after the anomaly scan 61.99 (41.54–92.49) <0.001 62.00 (41.06–93.63) <0.001
Unilateral RPD and no evidence of dilatation after the anomaly scan 1.01 (0.14–7.22) 0.987 1.06 (0.15–7.56) 0.950
Bilateral RPD and no evidence of dilatation after the anomaly scan 4.37 (1.07–17.76) 0.039 4.77 (1.17–19.47) 0.029
Unilateral RPD and evidence of dilatation after the anomaly scan 22.06 (10.02–48.56) <0.001 21.96 (9.91–48.67) <0.001
Bilateral RPD and evidence of dilatation after the anomaly scan 27.45 (10.24–73.53) <0.001 31.87 (11.72–86.68) <0.001
†Dilatation = evidence of dilatation of�7.1 mm later in pregnancy and/or evidence of dilatation of �7.1 mm postpartum.
‡Multivariable model also includes child gender, maternal age, Townsend score, gestational age at birth (multivariable model a better fit, likelihood ratio test p< 0.0001
in both cases).
Abbreviations: CI, confidence interval; HR, hazard ratio; RPD, renal pelvis dilatation.
https://doi.org/10.1371/journal.pmed.1002859.t004
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The SAIL Databank only includes healthcare information from Wales, which means that
we were unable to access information on pregnancy outcomes that occurred in facilities out-
side of Wales or on mothers and children who ordinarily received their healthcare outside of
Wales (for example, because they live along the border with England). The distribution of
pregnancy outcomes, congenital anomalies, and premature deliveries in the cohort included
in our analysis was comparable with those in published data for Wales [26], suggesting that
they were representative of the general obstetric population in Wales.
We used routinely available healthcare records on hospital admissions to capture data on
outcomes in this study, as these are available for the whole population in Wales. They are also
an indicator of clinically significant morbidity. However, we acknowledge that this means that
we have not included less severe outcomes in our analysis, such as UTIs managed in the com-
munity or in outpatients, underestimating the total burden of these outcomes in the general
population. It is also possible that provider practice may explain some of the increased risk in
admissions seen with persistent dilatation, as they may be more likely to admit a child with a
known kidney abnormality for treatment and observation. Without access to community or
outpatient data, we cannot assess the effect of this potential bias on the estimates obtained.
Obtaining records of radiological investigations later in pregnancy and postpartum was
challenging. Although guidelines state that all cases of RPD should receive follow-up investiga-
tions, we found later tests for only 88 of the 138 children with RPD (64%). This does not mean
that they did not have later investigations, but that we were unable to find a record of these.
Previous studies have restricted their samples to children with complete data on later preg-
nancy or postpartum scans (for example, see [34]), but this leads to an incomplete picture of
the natural history of RPD, especially as the characteristics of the excluded sample are usually
unreported. We were able to identify additional cases of ‘hydronephrosis’ from hospital admis-
sion codes and use this information in a sensitivity analysis to reclassify some children who
had no data on later radiological investigations. This strengthened our conclusions, as admis-
sion rates for children without persistent dilatation reduced in this analysis.
When information from later radiological investigations was available, it was clear that the
number, timing, and type of test was not consistent between children and that different termi-
nology and measurement thresholds were used to identify dilatation in the radiological
reports. Our findings suggest that regular training, clear reporting protocols, and frequent
audits to monitor follow-up rates and maintain reporting standards are needed if the manage-
ment of RPD is to be standardised.
Implications for further research
Our results are consistent with findings from previous case series that have used repeated pre-
natal measurement of dilatation to predict which children require postnatal follow-up [35].
However, there were some additional questions that we were unable to answer in this study.
For example, RPD was defined as an AP diameter of between 5.0 and 9.9 mm at the FAS, in
accordance with the definition used by the antenatal screening programme in Wales when the
data were collected [25]. Other classification systems [12] have further defined dilatation at the
FAS as ‘mild’ (<7.0 mm) and ‘moderate’ (7.0 to�10 mm), and some screening programmes
recommend that follow-up is only conducted when an RPD of�7.0 mm is identified at the
FAS [8]. We could not assess whether there was a difference in hospital admissions between
children with ‘mild’ or ‘moderate’ dilatation at the FAS, because the scan data collected for the
study only contained information on whether RPD was present or not (but no measurements).
Further studies are needed to document the natural history of dilatation and outcomes in chil-
dren according to the actual measurement of the AP diameter at the FAS. We were also unable
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to draw firm conclusions about other predictors of poorer outcomes, such as unilateral com-
pared with bilateral dilatation or the gender of the infant, because of sample size constraints. A
larger study is needed to compare these subgroups. However, there was some evidence that
children with bilateral RPD had a higher risk of hospital admissions even when there was no
later evidence of dilatation, which is consistent with how bilateral RPD is currently managed
in practice in Wales.
Two retrospective case series of patients known to specialist services have suggested that
including other parameters (such as calyceal dilatation, renal parenchymal thickness, renal
parenchymal appearance, bladder abnormalities, ureteral abnormalities, and oligohydram-
nios) in a formalised classification system is helpful in predicting which cases of dilatation will
resolve spontaneously and which children require later surgery [36,37]. Further research is
needed to fully understand the best combination of factors for predicting later pathology [9],
and therefore allow for the development of care pathways with fewer follow-up visits or inves-
tigations for children identified as low risk [34]. Small studies have also examined different
methods of visualising fetal urinary tract pathology (for example, conventional versus three-
dimensional ultrasound) [38] and the use of serum and urinary biomarkers in the postpartum
period to predict the risk of obstruction or impairment of renal function [39], but this research
is currently inconclusive.
We also found that there were children who did not have RPD at the FAS (either 5.0 to 9.9
mm or�10 mm) who were found to have dilatation at later investigations. This is consistent
with previous findings that not all cases of congenital dilatation are identified at the FAS [12].
In our study, this was a small group (44 of 21,101, 0.2%), but they had the highest rates of hos-
pital admissions overall. As we did not have access to the full report from the FAS or later med-
ical notes, we do not know why further investigations were conducted for these children.
However, their hospital admission codes suggested that they had multiple congenital renal
abnormalities and required more renal surgical procedures than children in the other groups.
It is therefore likely that these children had other anomalies identified at the FAS, which led to
the follow-up investigations and the repeated hospital admissions from an early age.
Implications for clinical practice
Clear protocols for reporting and further investigation and management of RPD are being devel-
oped (for example, [10]), and regular audits are needed to ensure that these are followed. The
effectiveness of continuous prophylactic antibiotics in the prevention of UTI in children with pre-
natally detected RPD is unclear, with evidence based on observational studies. The first trials of
prophylactic antibiotics for antenatal hydronephrosis with postnatally diagnosed vesicoureteral
reflux are under way (ClinicalTrials.gov Identifier: NCT01140516). Postnatal infections still occur
despite prophylaxis [40], and antibiotic resistance is higher with increased use [41]. Studies have
found an increased risk of UTI with severe prenatal dilatation in females, uncircumcised males,
and with specific postnatal diagnoses (ureteral dilatation, vesicoureteral reflux, or vesico-ureteric
junction obstruction) [42,43]. We did not have access to labour ward, outpatient, or general prac-
titioner records in this study and, as such, did not have information on which children were given
antibiotics after birth. Although we are therefore unable to comment on the role of antibiotics in
preventing UTI, the main cause of admission in our study was for UTIs and our results support
the need for close postnatal follow-up of children with persistent dilatation.
Conclusion
RPD at the FAS is an important finding because it identifies fetuses who require later investiga-
tions. When these investigations are normal, we do not yet have sufficient evidence to tell
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whether there is an increase in hospital admissions for urinary tract problems in childhood.
When there is persistent dilatation, hospital admission rates in childhood are higher. These
results can be used to improve counselling of parents. Although this was a large study in a rep-
resentative population of pregnant women in Wales, obtaining records of radiological investi-
gations after the FAS was challenging, and scans were not conducted or reported consistently.
Clear protocols for reporting and further investigation of RPD are being developed [10], and
regular audits are needed to ensure that these are followed. Further studies should examine
whether other characteristics at the FAS could improve the detection of renal pathology during
antenatal screening.
Supporting information
S1 STROBE checklist.
(DOC)
S1 Table. Codes used in the definition of hospital admissions.
(DOCX)
S2 Table. Characteristics of the first hospital admissions.
(DOCX)
S3 Table. Characteristics of all hospital admissions.
(DOCX)
S4 Table. HRs for time to first urinary tract hospital admission, also using dilatation iden-
tified during hospital admissions to inform the classification of the exposure groups. HR,
hazard ratio.
(DOCX)
S5 Table. HRs accounting for multiple admissions. HR, hazard ratio.
(DOCX)
S1 Renal Study Protocol.
(DOCX)
Acknowledgments
We would like to thank the individuals within the following organisations who contributed to
the management or running of the study: Antenatal Screening Wales; Gareth John and Louise
Richards in the NHS Wales Information Service; the antenatal screening coordinators, mid-
wives, and superintendent sonographers at all participating Health Boards (Abertawe Bro
Morgannwg University Health Board, Aneurin Bevan University Health Board, Betsi Cadwa-
ladr University Health Board, Cardiff and Vale University Health Board, Cwm Taf University
Health Board, and Hywel Dda University Health Board); and the members of the QA expert
panel. We also acknowledge the substantial contribution of all women who participated in the
study.
Author Contributions
Conceptualization: Lisa Hurt, Melissa Wright, Judith VanDerVoort, Susan Morris, Fiona
Brook, Maria Chapman, Nick A. Francis, David Fone, Shantini Paranjothy.
Data curation: Lisa Hurt, Melissa Wright, Joanne Demmler, Susan Morris, Fiona Brook,
David Tucker, Sinead Brophy.
Antenatal renal pelvis dilatation and hospital admissions in childhood
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002859 July 30, 2019 14 / 17
Formal analysis: Lisa Hurt, Melissa Wright.
Funding acquisition: David Fone, Shantini Paranjothy.
Investigation: Lisa Hurt, Judith VanDerVoort, Susan Morris, Fiona Brook, David Tucker,
David Fone, Shantini Paranjothy.
Methodology: Lisa Hurt, Melissa Wright, Judith VanDerVoort, Nick A. Francis, Rhian Daniel,
David Fone, Sinead Brophy, Shantini Paranjothy.
Writing – original draft: Lisa Hurt, Shantini Paranjothy.
Writing – review & editing: Lisa Hurt, Melissa Wright, Joanne Demmler, Judith VanDer-
Voort, Susan Morris, Fiona Brook, David Tucker, Maria Chapman, Nick A. Francis, Rhian
Daniel, David Fone, Sinead Brophy, Shantini Paranjothy.
References
1. Warady B, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol.
2007; 22(12):1999–2009. https://doi.org/10.1007/s00467-006-0410-1 PMID: 17310363
2. Couser W, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global
burden of major noncommunicable diseases. Kidney International. 2011; 80(12):1258–70. https://doi.
org/10.1038/ki.2011.368 PMID: 21993585
3. Watson A. Psychosocial support for children and families requiring renal replacement therapy. Pediatr
Nephrol. 2014; 29(7):1169–74. https://doi.org/10.1007/s00467-013-2582-9 PMID: 23963710
4. Song R, Yosypiv I. Genetics of congenital anomalies of the kidney and urinary tract. Pediatr Nephrol.
2011; 26(3):353–64. https://doi.org/10.1007/s00467-010-1629-4 PMID: 20798957
5. Harambat J, Van Stralen K, Kim J, Tizard E. Epidemiology of chronic kidney disease in children. Pediatr
Nephrol. 2012; 27(3):363–73. https://doi.org/10.1007/s00467-011-1939-1 PMID: 21713524
6. Nguyen H, Herndon C, Cooper C, Gatti J, Kirsch A, Kokorowski P, et al. The Society for Fetal Urology
consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol.
2010; 6(3):212–31. https://doi.org/10.1016/j.jpurol.2010.02.205 PMID: 20399145
7. Nef S, Neuhaus T, SpartàG, Weitz M, Buder K, Wisser J, et al. Outcome after prenatal diagnosis of
congenital anomalies of the kidney and urinary tract. Eur J Pediatr. 2016; 175(5):667–76. https://doi.
org/10.1007/s00431-015-2687-1 PMID: 26805407
8. Public Health England. NHS Fetal Anomaly Screening Programme Handbook. London: Public Health
England, August 2018.
9. Chow J, Koning J, Back S, Nguyen H, Phelps A, Darge K. Classification of pediatric urinary tract dilation:
the new language. Pediatr Radiol. 2017; 47(9):1109–15. https://doi.org/10.1007/s00247-017-3883-0
PMID: 28779200
10. Antenatal Screening Wales. Ultrasound Observations Pathways: isolated echogenic bowel, isolated
renal pelvis dilatation and isolated ventriculomegaly. Wales: Antenatal Screening Wales, 2018.
11. Garne E, Loane M, Wellesley D, Barisic I, Group EW. Congenital hydronephrosis: prenatal diagnosis
and epidemiology in Europe. J Pediatr Urol. 2009; 5(1):47–52. https://doi.org/10.1016/j.jpurol.2008.08.
010 PMID: 18977697
12. Nguyen H, Benson C, Bromley B, Campbell J, Chow J, Coleman B, et al. Multidisciplinary consensus
on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). J Pediatr
Urol. 2014; 10(6):982–98. https://doi.org/10.1016/j.jpurol.2014.10.002 PMID: 25435247
13. Braga L, Ruzhynsky V, Pemberton J, Farrokhyar F, DeMaria J, Lorenzo A. Evaluating practice patterns
in postnatal management of antenatal hydronephrosis: a national survey of Canadian pediatric urolo-
gists and nephrologists. Urology. 2014; 83(4):909–14. https://doi.org/10.1016/j.urology.2013.10.054
PMID: 24411215
14. Zanetta V, Rosman B, Bromley B, Shipp T, Chow J, Campbell J, et al. Variations in management of mild
prenatal hydronephrosis among maternal-fetal medicine obstetricians, and pediatric urologists and radi-
ologists. J Urology. 2012; 88(5):1935–9.
15. Lee R, Cendron M, Kinnamon D, Nguyen H. Antenatal hydronephrosis as a predictor of postnatal out-
come: a meta-analysis. Pediatrics. 2006; 118(2):586–93. https://doi.org/10.1542/peds.2006-0120
PMID: 16882811
Antenatal renal pelvis dilatation and hospital admissions in childhood
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002859 July 30, 2019 15 / 17
16. Braga L, Mijovic H, Farrokhyar F, Pemberton J, DeMaria J, Lorenzo A. Antibiotic prophylaxis for urinary
tract infections in antenatal hydronephrosis. Pediatrics. 2013; 131(1):e251–61. https://doi.org/10.1542/
peds.2012-1870 PMID: 23248229
17. Harding L, Malone P, Wellesley D. Antenatal minimal hydronephrosis: is its follow-up an unnecessary
cause of concern? Prenatal Diag. 1999; 19(8):701–5. PMID: 10451511
18. Walsh T, Hsieh S, Grady R, Mueller B. Antenatal hydronephrosis and the risk of pyelonephritis hospitali-
zation during the first year of life. Urology. 2007; 69(5):970–4. https://doi.org/10.1016/j.urology.2007.01.
062 PMID: 17482945
19. Hall M, Piepsz A, Alexander M, Schulman C, Avni F. Insights into the pathogenesis and natural history
of fetuses with renal pelvis dilatation. Eur Urol. 2005; 48(2):207–14. https://doi.org/10.1016/j.eururo.
2005.02.014 PMID: 16005373
20. Van Eerde A, Meutgeert M, De Jong T, Giltay J. Vesico-ureteral reflux in children with prenatally
detected hydronephrosis: a systematic review. Ultrasound Obst Gyn. 2007; 29(4):463–9.
21. Hothi D, Wade A, Gilbert R, Winyard P. Mild Fetal Renal Pelvis Dilatation—Much Ado About Nothing?
Clin J Am Soc Nephro. 2009; 4(1):168–77.
22. Swords K, Peters C. Neonatal and early infancy management of prenatally detected hydronephrosis.
Arch Dis Child Fetal Neonatal Ed. 2015; 100:F460–F4. https://doi.org/10.1136/archdischild-2014-
306050 PMID: 25605618
23. Oliveira E, Oliveira M, Mak R. Evaluation and management of hydronephrosis in the neonate. Curr Opin
Pediatr. 2016; 28:195–201. https://doi.org/10.1097/MOP.0000000000000321 PMID: 26807623
24. Hurt L, Wright M, Brook F, Thomas S, Dunstan F, Fone D, et al. The Welsh Study of Mothers and
Babies: protocol for a population-based cohort study to investigate the clinical significance of defined
ultrasound findings of uncertain significance. BMC Pregnancy Childb. 2014; 14(1):164.
25. Antenatal Screening Wales. Specific antenatal ultrasound findings: Guidelines for health professionals
in Wales. Cardiff, UK: Antenatal Screening Wales, 2004.
26. Hurt L, Wright M, Dunstan F, Thomas S, Brook F, Morris S, et al. Prevalence of defined ultrasound find-
ings of unknown significance at the second trimester fetal anomaly scan and their association with
adverse pregnancy outcomes: the Welsh study of mothers and babies population-based cohort. Prena-
tal Diag. 2016; 36(1):40–8. https://doi.org/10.1002/pd.4708 PMID: 26475362
27. World Health Organization. The ICD-10 classification of mental and behavioural disorders: Clinical
descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
28. Health and Social Scre Information Centre. OPCS classification of interventions and procedures version
4.5. London: TSO (The Stationery Office), 2009.
29. Ford D, Jones K, Verplancke J, Lyons R, John G, Brown G, et al. The SAIL Databank: building a
national architecture for e-health research and evaluation. BMC Health Serv Res. 2009; 9(1):157.
30. Lyons R, Jones K, John G, Brooks C, Verplancke J, Ford D, et al. The SAIL databank: linking multiple
health and social care datasets. BMC Med Inform Decis Mak. 2009; 9(1):3.
31. Yousaf S, Bonsall A. UK Townsend Deprivation Scores from 2011 census data. Colchester, UK: UK
Data Service, 2017.
32. White I, Royston P, Wood A. Multiple imputation using chained equations: issues and guidance for prac-
tice. Stat Med. 2011; 30(4):377–99. https://doi.org/10.1002/sim.4067 PMID: 21225900
33. White I, Royston P. Imputing missing covariate values for the Cox model. Stat Med. 2009; 28(15):1982–
98. https://doi.org/10.1002/sim.3618 PMID: 19452569
34. Zee R, Herndon C, Cooper C, Kim C, McKenna P, Khoury A, et al. Time to resolution: A prospective
evaluation from the Society for Fetal Urology hydronephrosis registry. J Pediatr Urol. 2017; 13(3):316.
e1–.e5.
35. Signorelli M, Cerri V, Taddei F, Groli C, Bianchi U. Prenatal diagnosis and management of mild fetal
pyelectasis: implications for neonatal outcome and follow-up. Eur J Obstet Gyn R B. 2005; 118(2):
154–9.
36. Hodhod A, Capolicchio J, Jednak R, El-Sherif E, El-Doray A, El-Sherbiny M. Evaluation of urinary tract
dilation classification system for grading postnatal hydronephrosis. J Urology. 2016; 195(3):725–30.
37. Kaspar C, Lo M, Bunchman T, Xiao N. The antenatal urinary tract dilation classification system accu-
rately predicts severity of kidney and urinary tract abnormalities. J Pediatr Urol. 2017; 13(5):485.e1–e7.
38. Duin L, Nijhuis J, Scherjon S, Vossen M, Willekes C. Comparison of conventional versus three-dimen-
sional ultrasound in fetal renal pelvis measurement and their potential prediction of neonatal uropathies.
J Matern-Fetal Neo M 2016; 29(15):2493–8.
39. Vemulakonda V, Yiee J, Wilcox D. Prenatal hydronephrosis: postnatal evaluation and management.
Curr Urol Reps. 2014; 15(8):430.
Antenatal renal pelvis dilatation and hospital admissions in childhood
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002859 July 30, 2019 16 / 17
40. Coelho G, Bouzada M, Lemos G, Pereira A, Lima B, Oliveira E. Risk factors for urinary tract infection in
children with prenatal renal pelvic dilatation. J Urology. 2008; 179(1):284–9.
41. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use
in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365
(9459):579–87. https://doi.org/10.1016/S0140-6736(05)17907-0 PMID: 15708101
42. Herz D, Merguerian P, McQuiston L. Continuous antibiotic prophylaxis reduces the risk of febrile UTI in
children with asymptomatic antenatal hydronephrosis with either ureteral dilation, high-grade vesicour-
eteral reflux, or ureterovesical junction obstruction. J Pediatr Urol. 2014; 10(4):650–4. https://doi.org/10.
1016/j.jpurol.2014.06.009 PMID: 25155409
43. Braga L, Farrokhyar F, D’cruz J, Pemberton J, Lorenzo A. Risk factors for febrile urinary tract infection
in children with prenatal hydronephrosis: a prospective study. J Urology. 2015; 193(5S):1766–71.
Antenatal renal pelvis dilatation and hospital admissions in childhood
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002859 July 30, 2019 17 / 17
